All News about OKYO Pharma Limited - Ordinary Shares




OKYO Pharma Files US IND Application For Dry Eye Disease Candidate
November 21, 2022
Via Benzinga

OKYO Pharma Announces U.S. IND Filing on OK-101 for the Treatment of Dry Eye Disease
November 21, 2022
From OKYO Pharma LTD
Via GlobeNewswire




OKYO Pharma Limited Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)
September 08, 2022
Via ACCESSWIRE


Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
August 30, 2022
Via Benzinga


















Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.